Brendan McDonnell, Director at HOLLIS EDEN PHARMACEUTICALS INC /DE/ (HEPH), bought 10,000 shares at $5.82 ($57K) on 2006-12-12, disclosed to the SEC on 2006-12-12.
Open-market purchase of $57k HEPH by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.50 | 3,640 | $20K | 35.1% |
| 2 | $5.82 | 6,360 | $37K | 64.9% |
| Total | $5.70 avg | 10,000 | $57K | 100% |
| Filing → |